1h Free Analyst Time
The pharmaceutical contract research and manufacturing market is forecasted to grow by USD 141.3 billion during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the pharmaceutical contract research and manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, growing need to focus on core competencies, and strong research funding.
The pharmaceutical contract research and manufacturing market is segmented as below:
By Service
- CMO
- CRO
By End-user
- Big pharmaceuticals
- Small and medium-sized pharmaceuticals
- Generic pharmaceuticals
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
The report on the pharmaceutical contract research and manufacturing market covers the following areas:
- Pharmaceutical contract research and manufacturing market sizing
- Pharmaceutical contract research and manufacturing market forecast
- Pharmaceutical contract research and manufacturing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global pharmaceutical contract research and manufacturing market: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Catalent Inc., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd, DR Reddys Laboratories Ltd., ICON PLC, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, OPTIMAPHARM d.o.o., Parexel International Corp., PCI Pharma Services, Recipharm AB, Samsung Electronics Co. Ltd., Syneos Health Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of US FDA approved manufacturing facilities."
According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Almac Group Ltd.
- Boehringer Ingelheim International GmbH
- Cadila Pharmaceuticals Ltd.
- Catalent Inc.
- Charles River Laboratories International Inc.
- Cmic Holdings Co. Ltd
- Dr Reddys Laboratories Ltd.
- ICON plc
- IQVIA Holdings Inc.
- Laboratory Corp. of America Holdings
- Lonza Group Ltd.
- Lupin Ltd.
- Novotech Health Holdings
- OPTIMAPHARM d.o.o.
- Parexel International Corp.
- PCI Pharma Services
- Recipharm AB
- Samsung Electronics Co. Ltd.
- Syneos Health Inc.
- Thermo Fisher Scientific Inc.
